A detailed history of Decision Point Financial, LLC transactions in Mannkind Corp stock. As of the latest transaction made, Decision Point Financial, LLC holds 1,348 shares of MNKD stock, worth $9,786. This represents 0.0% of its overall portfolio holdings.

Number of Shares
1,348
Previous 1,348 -0.0%
Holding current value
$9,786
Previous $7,000 14.29%
% of portfolio
0.0%
Previous 0.0%

Shares

1 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2022

Sep 26, 2023

BUY
$3.02 - $5.37 $4,070 - $7,238
1,348 New
1,348 $7.1 Million

Others Institutions Holding MNKD

About MANNKIND CORP


  • Ticker MNKD
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 257,338,000
  • Market Cap $1.87B
  • Description
  • MannKind Corporation, a biopharmaceutical company, focuses on the development and commercialization of inhaled therapeutic products for endocrine and orphan lung diseases in the United States. It offers Afrezza, an inhaled insulin used to improve glycemic control in adults with diabetes. It also promotes Thyquidity to adult and pediatric endocri...
More about MNKD
Track This Portfolio

Track Decision Point Financial, LLC Portfolio

Follow Decision Point Financial, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Decision Point Financial, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Decision Point Financial, LLC with notifications on news.